Boston Scientific Corp logo

Boston Scientific Corp - SER A

(Preferred)
NYSE:BSXpA.PFD (USA)   PRF PERPETUAL USD 100 - Ser A
$ 122.18 +2.83 (+2.37%) 09:42 AM EST
64.01
P/B:
5.21
Volume:
1.89M
Avg Vol (2M):
101.68K
Also Trade In:
Volume:
1.89M
Avg Vol (2M):
101.68K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Boston Scientific Corp ( ) from 2020 to Mar 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Boston Scientific stock (BSXpA.PFD) PE ratio as of Mar 29 2024 is 64.01. More Details

Boston Scientific Corp (BSXpA.PFD) PE Ratio (TTM) Chart

To

Boston Scientific Corp (BSXpA.PFD) PE Ratio (TTM) Historical Data

Total 0
  • 1
Boston Scientific PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Boston Scientific Corp (BSXpA.PFD) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.